Sort
50,496 grants matching “lung cancer”
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$1,003,255Chi-Chao Chan · National Eye Institute · ZIA · FY2012 · EY
Exosomes as carriers of cancer therapeutics
$1,002,901Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · CA
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
$1,002,877Susan Bates · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2021 · GM
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2025 · GM
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2023 · GM
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2024 · GM
Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock
$1,002,711Aziz Sancar · Univ Of North Carolina Chapel Hill · R35 · FY2022 · GM
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
$1,002,483Valerie Humblet · Collagen Medical, Llc · R44 · FY2017 · CA
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
$1,002,427David Salomon · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Non-Clinical Pharmacology of CX-01
$1,002,340Galina Vid · Ceramedix Holding, Llc · R44 · FY2024 · AI
Mitogenesis Networks
$1,002,336Forest M White · Massachusetts Institute Of Technology · U54 · FY2014 · CA
Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer
$1,002,148Avni A Argun · Giner, Inc. · R44 · FY2021 · CA
SPORE in Lung Cancer
$1,002,096Bruce E. Johnson · Dana-Farber Cancer Inst · P20 · FY2007 · CA
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
$1,002,053Diana J Wilkie · University Of Florida · U54 · FY2024 · CA
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
$1,001,898Upendra Marathi · 7 Hills Pharma, Llc · R42 · FY2019 · CA
Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer
$1,001,446Eric L Grogan · Vanderbilt University Medical Center · U01 · FY2023 · CA
Appalachia Community Cancer Network
$1,001,201Mark B. Dignan · University Of Kentucky · U01 · FY2007 · CA
Clinical production of viral vectors for cancer gene therapy
$1,001,150Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
DNA evaluation of fragments for early interception (DELFI) of Lung cancer
$1,001,112Victor E Velculescu · Johns Hopkins University · U01 · FY2024 · CA
Preclinical development of TIMP-2 as a biologic therapy for cancer
$1,001,040William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Development of CD4 TCR-engineered T cell immunotherapy in triple-negative breast cancer
$1,001,029Yicheng Wang · Immunova Therapeutics, Llc · R44 · FY2024 · CA
Exisulind for Chemoprevention of Lung Cancer
$1,000,956Md, Jhanelle Gray · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2007 · CA
BIOMARKERS OF LUNG CANCER SUSCEPTIBILITY IN MINORITIES
$1,000,739University Of California San Francisco · R01 · FY2001 · ES
MicroRNA-based Radiation Biodosimeter (MiRAD) Phase II
$1,000,000Claude J. Rogers · Chromologic, Llc · R44 · FY2019 · AI